Skip to Main Content

Author Details

Julie Livingstone
University of California los angeles
2011
34
20
Timothy Clark (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36610996A polygenic two-hit hypothesis for prostate cancer.J Natl Cancer Inst2023
36178522The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.Acta Neuropathol2022
35437583Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.Cancer Epidemiol Biomarkers Prev2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
34337539Decreased ATM Protein Expression Is Substantiated with PTEN Loss in Defining Aggressive Phenotype of Prostate Cancer Associated with Lethal Disease.Eur Urol Open Sci2021
34824250The telomere length landscape of prostate cancer.Nat Commun2021
34541033Loss of CDCP1 triggers FAK activation in detached prostate cancer cells.Am J Clin Exp Urol2021
34716314Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse.Nat Commun2021
34068856Copy Number Profiles of Prostate Cancer in Men of Middle Eastern Ancestry.Cancers (Basel)2021
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
31974375Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.Nat Commun2020
33299664Immune-focused multi-omics analysis of prostate cancer: leukocyte Ig-Like receptors are associated with disease progression.Oncoimmunology2020
30685078Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.Eur Urol2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
31748536The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact.Nat Commun2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
30643250Molecular landmarks of tumor hypoxia across cancer types.Nat Genet2019
29295717Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.BMC Cancer2018
29921600Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.J Cell Biol2018
29681457The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression.Cell2018
28067867Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.Nat Commun2017
28511883A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.Eur Urol2017
28068672Genomic hallmarks of localized, non-indolent prostate cancer.Nature2017
27079753Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.Alzheimers Dement2016
26933086Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.Cancer Res2016
26005866Spatial genomic heterogeneity within localized, multifocal prostate cancer.Nat Genet2015
25884794A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.BMC Cancer2015
25071152p66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition.Mol Cell Biol2014
25284793The prognostic ease and difficulty of invasive breast carcinoma.Cell Rep2014
22020329Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.Oncogene2012
21245318Cut homeobox 1 causes chromosomal instability by promoting bipolar division after cytokinesis failure.Proc Natl Acad Sci U S A2011
21741851Transcripts of soybean isoflavone 7-O-glucosyltransferase and hydroxyisoflavanone dehydratase gene homologues are at least as abundant as transcripts of their well known counterparts.Plant Physiol Biochem2011
  • 1 - 34 of 34

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 15
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 13
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 9
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 7
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 28
Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 39
Paul Lloyd
Bluestar Genomics Inc.
Career Start Year 2010
Number of shared co-authors 21
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 11
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 19
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 34
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 8
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 52
John R Prensner
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 27
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 10
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 32
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 4
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 13
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 36
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 16
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 13
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 18
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 7
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 26
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 16
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 17
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 19
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 54
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 57

Collaborators

Paul C Boutros
University of California los angeles
Co-authored papers 27
Robert G Bristow
University of Toronto
Co-authored papers 14
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 13
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 13
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 11
Takafumi N Yamaguchi
University of California los angeles
Co-authored papers 10
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 9
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers 9
Fouad Yousif
Ontario Institute for Cancer Research
Co-authored papers 7
Emilie Lalonde
University of Pennsylvania
Co-authored papers 7
Shadrielle Melijah G Espiritu
Ontario Institute for Cancer Research
Co-authored papers 6
Melvin L K Chua
National Cancer Centre Singapore
Co-authored papers 6
Kathleen E Houlahan
University of California los angeles
Co-authored papers 6
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 6
Natalie S Fox
University of California los angeles
Co-authored papers 6
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 6
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 5
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 5
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 5
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers 5
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 5
Val??rie Picard
Centre de recherche du CHU de Quebec-Universite Laval
Co-authored papers 5
Colin C Collins
University of British Columbia
Co-authored papers 5
Vinayak Bhandari
University of Toronto
Co-authored papers 5
Alice Meng
Tufts University School of Medicine
Co-authored papers 4
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Co-authored papers 4
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 4
Release 1.2